Oyen WJ - Search Results

1

Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides.

Vegt E, Eek A, Oyen WJ, de Jong M, Gotthardt M, Boerman OC. Vegt E, et al. Among authors: oyen wj. Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):226-34. doi: 10.1007/s00259-009-1239-1. Epub 2009 Sep 1. Eur J Nucl Med Mol Imaging. 2010. PMID: 19722105 Free PMC article.

2

Radioimmunotherapy of B-cell non-Hodgkin's lymphoma.

Postema EJ, Boerman OC, Oyen WJ, Raemaekers JM, Corstens FH. Postema EJ, et al. Among authors: oyen wj. Eur J Nucl Med. 2001 Nov;28(11):1725-35. doi: 10.1007/s002590100570. Eur J Nucl Med. 2001. PMID: 11702116 Review.

3

Scintigraphic imaging using 99mTc-labeled PEG liposomes allows early detection of experimental invasive pulmonary aspergillosis in neutropenic rats.

Becker MJ, Dams ET, de Marie S, Oyen WJ, Boerman OC, Fens MH, Verbrugh HA, Bakker-Woudenberg IA. Becker MJ, et al. Among authors: oyen wj. Nucl Med Biol. 2002 Feb;29(2):177-84. doi: 10.1016/s0969-8051(01)00291-8. Nucl Med Biol. 2002. PMID: 11823122

4

131 I-cG250 monoclonal antibody immunoscintigraphy versus [18 F]FDG-PET imaging in patients with metastatic renal cell carcinoma: a comparative study.

Brouwers AH, Dorr U, Lang O, Boerman OC, Oyen WJ, Steffens MG, Oosterwijk E, Mergenthaler HG, Bihl H, Corstens FH. Brouwers AH, et al. Among authors: oyen wj. Nucl Med Commun. 2002 Mar;23(3):229-36. doi: 10.1097/00006231-200203000-00005. Nucl Med Commun. 2002. PMID: 11891480 Clinical Trial.

5

Effects of coligand variation on the in vivo characteristics of Tc-99m-labeled interleukin-8 in detection of infection.

Rennen HJ, van Eerd JE, Oyen WJ, Corstens FH, Edwards DS, Boerman OC. Rennen HJ, et al. Among authors: oyen wj. Bioconjug Chem. 2002 Mar-Apr;13(2):370-7. doi: 10.1021/bc015579k. Bioconjug Chem. 2002. PMID: 11906276

6

Fluorinated amino acids for tumour imaging with positron emission tomography.

Laverman P, Boerman OC, Corstens FH, Oyen WJ. Laverman P, et al. Among authors: oyen wj. Eur J Nucl Med Mol Imaging. 2002 May;29(5):681-90. doi: 10.1007/s00259-001-0716-y. Epub 2002 Jan 11. Eur J Nucl Med Mol Imaging. 2002. PMID: 11976809 Review.

7

99mTc-HMPAO-labeled autologous versus heterologous leukocytes for imaging infection.

Gratz S, Rennen HJ, Boerman OC, Oyen WJ, Mast P, Behr TM, Corstens FH. Gratz S, et al. Among authors: oyen wj. J Nucl Med. 2002 Jul;43(7):918-24. J Nucl Med. 2002. PMID: 12097463

8

Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.

Janssen ML, Oyen WJ, Dijkgraaf I, Massuger LF, Frielink C, Edwards DS, Rajopadhye M, Boonstra H, Corstens FH, Boerman OC. Janssen ML, et al. Among authors: oyen wj. Cancer Res. 2002 Nov 1;62(21):6146-51. Cancer Res. 2002. PMID: 12414640

9

Targeting cytokine/chemokine receptors: a challenge for molecular nuclear medicine.

Signore A, Chianelli M, Bei R, Oyen W, Modesti A. Signore A, et al. Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):149-56. doi: 10.1007/s00259-002-0941-z. Epub 2002 Sep 21. Eur J Nucl Med Mol Imaging. 2003. PMID: 12520385 Review.

10

Pretargeted radioimmunotherapy of cancer: progress step by step.

Boerman OC, van Schaijk FG, Oyen WJ, Corstens FH. Boerman OC, et al. Among authors: oyen wj. J Nucl Med. 2003 Mar;44(3):400-11. J Nucl Med. 2003. PMID: 12621007 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results